1. Osborne MP, Paneth M, Hinson KFW.

Starch granules in the pericardium as a cause of post-cardiotomy syndrome.

Thorax 1974;29:199-203


2. Osborne MP.

Penile Parkinsonism.

Postgraduate Medical Journal 1974;50:523-524


3. Honey M, Lincoln JCR, Osborne MP, DeBono D.

Coarctation of the aorta with right aortic arch.

British Heart Journal 1975;37:937-945


4. Osborne MP, Hamilton G, Shalley M.

Axial volvulus of Meckel's diverticulum.

Postgraduate Medical Journal 1978;54:692-693


5. Bion J, Coleman JC, Osborne MP.

An unusual postoperative pneumonia.

Journal of the Royal Society of Medicine 1978;71:523-526


6. Ryman BE, Jewkes RF, Jeyasingh K, Osborne MP, Patel HM, Richardson VJ, Tyrell DA.

Potential applications of liposomes to therapy.

Annals of the New York Academy of Sciences 1978;308:281-307


7. Osborne MP, Murray-Lyon IM, Reynolds K.

Dacron bypass grafting in the relief of obstructive jaundice.

Lancet 1979;1:1323-1325


8. Osborne MP, Richardson VJ, Jeyasingh K, Ryman BE.

Radionuclide labeled liposomes - a new lymph node imaging agent.

International Journal of Nuclear Medicine and Biology 1979;6:75-83


9. Osborne MP, Jeyasingh K, Jewkes RF, Burns JI.

The preoperative detection of internal mammary lymph node metastases in breast cancer.

British Journal of Surgery 1979;66:813-818


10. Osborne MP.

Lymph node scanning for breast cancer.

Transactions of the Medical Society of London 1979;95:43-45


11. Greening WP, Sarker SK, Osborne MP.

Hemiagenesis of the thyroid gland.

British Journal of Surgery 1980;67:446-448


12. Sarker SK, Osborne MP, Harmer CL, Greening WP.

Thyroid cancer - a study of 220 cases.

Indian Journal of Cancer 1980;17:11-18


13. Osborne MP.

The detection of lymphatic metastases in breast cancer.

Master of Surgery Thesis, University of London, 1980


14. Osborne MP, Richardson VJ, Jeyasingh K, Ryman BE.

Potential applications of radionuclide-labeled liposomes in the detection of the lymphatic spread of cancer.

International Journal of Nuclear Medicine, Biology and Physics 1982;9:47-51


15. Osborne MP, Griffiths JD, Shaw HJ.

Colon-transposition in the management of upper gastrointestinal cancer.

Cancer 1982;50:257-264


16. Freeman JL, Brondbo K, Osborne MP, Novek AM, Shaw HJ, Rubin A, Chapnick JS.

Greater momentum used for carotid cover after pharyngolaryngoesophagectomy and gastric "pull-up" or colonic "swing".

Archives of Otolaryngology 1982;108:685-687


17. Osborne MP, Payne JH, Richardson VJ, McCready VR, Ryman BE.

The preoperative detection of axillary lymph node metastases in breast cancer by isotope imaging. British Journal of Surgery 1983;70:141-144


18. Osborne MP.

Pedal microlymphangiography in the experimental animal.

Lymphology 1983;16:31-34


19. Osborne MP, Rosen PP, Lesser ML, Schwartz MK, Menendez-Botet CJ, Fishman J, Kinne DW,

Beattie EJ Jr.

The relationship between family history, exposure to exogenous hormones and estrogen receptor protein in breast cancer.

Cancer 1983;51:2134-2138


20. Fracchia AA, Cody HS, Eisenberg BL, Osborne MP, Owens JC, Weingrad DN, Caron AS,

Urmacher C, Bretsky S.

Stage II carcinoma of the breast: The importance of adequate local therapy.

Breast 1983;9:23-29


21. Osborne MP, Ormiston N, Harmer CL, McKinna JA, Baker J, Greening WP.

Breast conservation in the treatment of early breast cancer: A 20-year follow-up.

Cancer 1984;53:349-355


22. Petrek JA, Dukoff R, Crowe J, Osborne MP, Kinne DW.

Pregnancy-associated breast cancer.

Surgical Forum 1986;38:478-480


23. Axelrod DM, Bockman RS, Wong GY, Osborne MP, Kinne DW, Brennan MF.

Distinguishing features of primary hyperparathyroidism in patients with breast cancer.

Cancer 1987;60:160-1624


24. McCormick B, Kinne D, Petrek J, Osborne MP, Cox L, Shank B, Hellman S, Yahalom J, Rosen PP.

Limited resection for breast cancer: A study of inked specimen margins before radiotherapy.

International Journal of Radiation Oncology, Biology, Physics 1987;13:1667-1671


25. Cote RJ, Rosen PP, Hakes TB, Sedira M, Bazinet M, Kinne DW, Old LJ, Osborne MP.

Monoclonal antibodies detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease.

American Journal of Surgical Pathology 1988;12:333-340


26. Axelrod DM, Menendez-Botet CJ, Kinne DW, Osborne MP.

Levels of estrogen and progesterone receptor proteins in patients with breast cancer during various phases of the menstrual cycle.

Cancer Investigation 1988;6:7-14


27. Wesson MF, Osborne MP, Petrek J, Kinne D, McCormick B.

Iridium-192 implants for primary breast cancer: Experience with concomitant limited resection or re-excision.

Endocurietherapy/Hyperthermia Oncology 1988;4:149-153


28. McCormick B, Wesson MF, Cox L, Osborne MP, Petrek JA, Kinne DW.

Iridium-192 implants for primary breast cancer: Experience with placement at the time of wide local excision.

International Journal of Radiation Oncology, Biology and Physics 1988;15:745-748


29. Telang NT, Basu A, Kurihara H, Osborne MP, Modak MJ.

Modulation in the expression of murine mammary tumor virus, ras proto-oncogene and of alveolar hyperplasia by fatty acids in mouse mammary explant cultures.

Anticancer Research 1988;8:971-976


30. Osborne MP, Karmali RA, Hershcopf RJ, Bradlow HL, Kourides IA, Williams WR, Rosen PP,

Fishman J.

Omega-3 fatty acids: modulation of estrogen metabolism and potential for breast cancer prevention.

Cancer Investigation 1988;6:629-631


31. Dermatis H, Rowland J, Miransky J, Kerner J, Osborne MP, Holland J.

Consent and compliance in chemoprevention trials.

Cancer Investigation 1988;6:633-635


32. Kinne DW, Petrek JA, Osborne MP, Fracchia AA, DePalo AA, Rosen PP.

Breast carcinoma in-situ.

Archives of Surgery 1989;124:33-36


33. Osborne MP, Asina S, Wong GY, Old LJ, Cote RJ.

Immunofluorescent monoclonal antibody detection of breast cancer in bone marrow: a study of sensitivity in a model system.

Cancer Research 1989;49:2510-2513


34. Telang NT, Bradlow HL, Kurihara H, Osborne MP.

In vitro biotransformation of estradiol by explant cultures of murine mammary tissues.

Breast Cancer Research and Treatment 1989;13:173-181


35. Baron PL, Moore MP, Kinne DW, Candela FC, Osborne MP, Petrek JA.

Occult breast cancer presenting with axillary metastases: updated management.

Archives of Surgery 1990;125:210-215


36. Osborne MP, Telang NT, Kaur S, Bradlow HL.

Influence of chemo-preventive agents, tamoxifen and hydroxyphenylretinamide (HPR) on estradiol metabolism and mammary preneoplasia in C3H mice.

Steroids 1990;55:114-119


37. Telang NT, Axelrod DM, Bradlow HL, Osborne MP.

Metabolic biotransformation of estradiol in human mammary explant cultures.

Annals of the New York Academy of Sciences 1990;586:70-78


38. Telang NT, Basu A, Modak MJ, Osborne MP.

Cellular ras proto-oncogene expression in human mammary explant cultures: A potential marker for chemical carcinogenesis.

Annals of the New York Academy of Sciences 1990;586:230-237


39. Telang NT, Osborne MP, Sweterlitsch LA, Narayanan R.

Neoplastic transformation of mouse mammary epithelial cells by deregulated myc expression.

Cell Regulation 1990;1:863-872


40. Dershaw DD, McCormick B, Cox L, Osborne MP.

Differentiation of benign and malignant local tumor recurrence after lumpectomy.

American Journal of Roentgenology 1990;155:35-38


41. Seres DS, Bunk MJ, Osborne MP, Rivlin RS, Tiwari RK.

Effects of marginal dietary zinc deficiency and vitamin E supplementation on hepatic adenine dinucleotide phosphoribosyl transferase activity in female Sprague-Dawley rats.

Nutrition Research 1991;11:337-345


42. Telang NT, Axelrod DM, Wong GY, Bradlow HL, Osborne MP.

Biotransformation of estradiol by explant cultures of human breast tissue.

Steroids 1991;56:37-43


43. Dershaw DD, Panicek DM, Osborne MP.

Significance of lymph nodes visualized by the mammographic axillary view.

Breast Diseases 1991;4:271-280


44. Tiwari RK, Wong GY, Mukhopadhyay B, Telang NT, Liu J, Hakes TB, Osborne MP.

Interferon-alpha and gamma mediated gene responses in a human breast carcinoma cell line.

Breast Cancer Research and Treatment 1991;18:33-41


45. Osborne MP, Asina S, Wong GY, Old LJ, Cote RJ, Rosen PP.

Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow.

Cancer Research 1991;51:2706-2709


46. Telang NT, Narayanan R, Bradlow HL, Osborne MP.

Coordinated expression of intermediate biomarkers for tumorigenic transformation in ras-transfected mouse mammary epithelial cells.

Breast Cancer Research and Treatment 1991;18:155-163


47. Cote RJ, Rosen PP, Lesser ML, Old LJ, Osborne MP.

Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.

Journal of Clinical Oncology 1991;9:1749-1756


48. Telang NT, Kurihara H, Wong GY, Bradlow HL, Osborne MP.

Preneoplastic transformation in mouse mammary tissue: identification and validation of intermediate biomarkers for chemoprevention.

Anticancer Research 1991;11:1021-1028


49. Michnovicz JJ, Telang NT, Osborne MP, Bradlow HL.

Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice.

Carcinogenesis 1991;12:1571-1574


50. Tiwari RK, Mukopadhyay B, Telang NT, Osborne MP.

Modulation of gene expression by selected fatty acids in human breast cancer cells.

Anticancer Research 1991;11:1383-1388


51. Tiwari RK, Wong GY, Liu I, Miller D, Osborne MP.

Augmentation of cytotoxicity using combinations of interferon (types I and II), tumor necrosis factor and tamoxifen in MCF-7 cells.

Cancer Letters 1991;61:45-52


52. Osborne MP, Borgen PI, Wong GY, Rosen PP, McCormick B.

Salvage mastectomy for local-regional relapse after breast conserving surgery and radiation therapy. Surgery, Gynecology and Obstetrics 1992;174:189-194


53. Osborne MP, Ruperto JF, Crowe JP, Rosen PP, Telang NT.

The effect of tamoxifen on preneoplastic cell proliferation in N-nitroso-N-methylurea-induced mammary carcinogenesis.

Cancer Research 1992;52:1477-1480


54. Narayanan R, Lawlor KG, Schaapveld RQJ, Cho KR, Vogelstein B, Tran PB-V, Osborne MP,

Telang NT.

Antisense RNA to the putative tumor-suppressor gene DCC transforms Rat-1 fibroblasts.

Oncogene 1992;7:553-561


55. Telang NT, Suto A, Wong GY, Osborne MP, Bradlow HL.

Induction by estrogen metabolite 16a-hydroxestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells.

Journal of the National Cancer Institute 1992;84:634-636


56. Tiwari RK, Borgen PI, Cordon-Cardo C, Osborne MP.

HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis.

Anticancer Research 1992;12:419-426


57. Willard W, Borgen P, Bol R, Tiwari R, Osborne MP.

Cowden's Disease: A case report with analyses at the molecular level.

Cancer 1992;69:2969-2974


58. Suto A, Bradlow HL, Wong GY, Osborne MP, Telang NT.

Persistent endocrine responsiveness of ras oncogene-transformed mouse mammary epithelial cells.

Steroids 1992;57:262-268


59. Telang NT, Bradlow HL, Osborne MP.

Molecular and endocrine biomarkers in non-involved breast: relevance to cancer chemoprevention.

Journal of Cellular Biochemistry 1992;16:161-169


60. Borgen PI, Vlamis V, Potter C, Hoffman B, Wong GY, Kinne DW, Osborne MP, McKinnon WMP.

Current management of male breast cancer: A review of 104 cases.

Annals of Surgery 1992;215:451-459


61. Lawler KG, Telang NT, Osborne MP, Schaapveld RQ, Cho KR, Vogelstein B, Narayanan R.

Antisense RNA to the putative tumor suppressor gene "Deleted in Colorectal Cancer" transforms fibroblasts.

Annals of the New York Academy of Sciences 1992;660:283-285


62. Yahalom J, Petrek JA, Biddinger PW, Kessler S, Dershaw DD, McCormick B, Osborne MP, Rosen PP.

Breast cancer in patients irradiated for Hodgkin’s disease: A clinical and pathological analysis of 45 events in 37 patients.

Journal of Clinical Oncology 1992;10:1674-1681


63. Tiwari RK, Mukhopadhyay B, Osborne MP.

Desensitization of human breast cancer cells by interferon.

International Journal of Oncology 1992;1:601-605


64. Dershaw DD, McCormick B, Osborne MP.

Detection of local recurrence after conservation therapy for breast carcinoma.

Cancer 1992;70:493-496


65. Bradlow HL, Michnovicz JJ, Telang NT, Osborne MP, Goldin BR.

Diet, oncogenes and tumor viruses as modulators of estrogen metabolism in vivo and in vitro.

Cancer Prevention and Detection 1992;16:1 S38-S42


66. Suto A, Bradlow HL, Kubota T, Kilajma M, Wong GY, Osborne MP, Telang NT.

Alterations in proliferative and endocrine responsiveness of human mammary carcinoma cells by prototypic tumor suppressing agents.

Steroids 1993;58:215-219


67. Breuer B, Kash K, Rosenthal G, Diemer K, Osborne MP, Miller DG.

Reporting bilaterality status in first-degree relatives with breast cancer: A validity study.

Genetic Epidemiology 1993;10:245-256


68. Tiwari RK, Guo L, Mukhopadhyay B, Wong GY, Osborne MP.

Gene induction by interferons in BT-20 cells.

International Journal of Oncology 1993;481-487


69. Garg A, Suto A, Osborne MP, Gupta RC, Telang NT.

Expression of biomarkers for transformation in 7,12-dimethylbenz[a]anthracene-treated mammary epithelial cells.

International Journal of Oncology 1993;3:185-189


70. Breuer B, Luo J, DeVivo I, Pincus M, Tatum AH, Daucher J, Minick R, Osborne MP, Miller DG, Nowak E, Cody H, Carney WP, Brandt-Rauf PW.

Detection of elevated c-erbB-2 oncoprotein in the serum and tissue in breast cancer.

Medical Science Research 1993;21:383-384


71. DeVivo I, Breuer B, Smith S, Milling C, Pincus M, Tatum AH, Daucher J, Niman H, Minick R, Osborne MP, Miller DG, Nowak E, Cody H, Brandt-Rauf PW.

Detection of serum c-myc oncoprotein in cancer patients by immunoblot.

Medical Science Research 1993;21:345-347


72. Osborne MP, Bradlow HL, Wong GYC, Telang NT.

Upregulation of estradiol C16?-hydroxylation in human breast tissue: A potential biomarker of breast cancer risk.

Journal of the National Cancer Institute 1993;85:1917-1920


73. Suto A, Bradlow HL, Wong GYC, Osborne MP, Telang NT.

Experimental down-regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells.

Breast Cancer Research and Treatment 1993;27:193-202


74. Tiwari RK, Guo L, Bradlow HL, Telang NT, Osborne MP.

Selective responsiveness of human breast cancer cells to indole-3-carbinol, a chemopreventive agent.

Journal of the National Cancer Institute 1994;86:126-131


75. Sepkovic DW, Bradlow HL, Michnovicz J, Murtezani S, Levy I, Osborne MP.

Catechol estrogen production in rat microsomes after treatment with indole-3-carbinol, ascorbigen, or B-naphthaflavone: A comparison of stable isotope dilution gas chromatography-mass spectrometry and radiometric methods.

Steroids 1994;59:318-322


76. Telang NT, Bradlow HL, Osborne MP.

Effect of tamoxifen on mammary preneoplasia: Relevance to chemopreventive intervention

Cancer Detection and Prevention 1994;18:313-321


77. Osborne MP, Rosen PP.

Detection and management of bone marrow micrometastases in breast cancer.

Oncology 1994;8:25-31


78. Kash KM, Holland JC, Miller DG, Osborne MP.

Psychological distress and adherence to screening behaviors in women at genetic risk for breast cancer.

Psychosomatic Medicine 1994;56:148-149


79. Bradlow HL, Michnovicz JJ, Halper M, Miller DG, Wong GY, Osborne MP.

Long-term responses of women to indole-3-carbinol or a high fiber diet.

Cancer Epidemiology Biomarkers and Prevention 1994;3:591-595


80. Osborne MP, Simmons RM.

Salvage surgery for recurrence after breast conservation.

World Journal of Surgery 1994;18:93-97


81. Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, Hoskins K, Weber B, Castilla L, Erdos M, Brody L, Friedman L, Ostermeyer E, Szabo C, King MC, Jharwar S, Offit K, Norton L, Gilewski T, Lubin M, Osborne MP, Black D, Boyd M, Steel M, Ingles S, Haile R, Lindblom A, Olsson H, Borg A, Bishop DT, Solomon E, Radice P, Spatti G, Gayther S, Ponder B, Warren W, Stratton M, Liu Q, Fujimura F, Lewis C, Skolnick M, Goldgar E.

A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene.

Journal of the American Medical Association 1995;273:535-541


82. Valdimarsdottir HB, Bovbjerg DH, Kash KM, Holland JC, Osborne MP, Miller DG.

Psychological distress in women with a familial risk of breast cancer.

Psycho-Oncology 1995;4:133-141


83. Li G, Osborne MP, Tiwari RK.

Anti-proliferative effects of garlic constituents in cultured human breast cancer cells.

Oncology 1995;2:787-791


84. Fishman J, Osborne MP, Telang NT.

The role of estrogen in mammary carcinogenesis.

Annals of the New York Academy of Sciences 1995;768:91-100


85. Araki R, Inoue S, Osborne MP, Telang NT.

Chemoprevention of mammary preneoplasia. In-vitro effects of a green tea polyphenol.

Annals of the New York Academy of Sciences 1995;768:215-222


86. Kash KM, Holland JC, Osborne MP, Miller DG.

Psychological counseling strategies for women at risk of breast cancer.

Journal of the National Cancer Institute, Monogr. 1995;17:73-79


87. Sepkovic DW, Bradlow HL, Ho G, Hankinson SE, Gong L, Osborne MP, Fishman J.

Estrogen metabolite ratios and risk assessment of hormone-related cancers. Assay validation and prediction of cervical cancer risk.

Annals of the New York Academy of Sciences 1995;768:312-316


88. Bradlow HL, Sepkovic DW, Telang NT, Osborne MP.

Indole-3-carbinol. A novel approach to breast cancer prevention.

Annals of the New York Academy of Sciences 1996;768:180-200


89. Osborne MP.

Hormonal intervention in breast cancer: Past, present and future.

Annals of the New York Academy of Sciences 1996;784:427-432


90. Arzimanoglou II, Lallas T, Osborne MP, Barber H, Gilbert F.

Microsatellite instability differences between familial and sporadic ovarian cancers.

Carcinogenesis 1996;9:1799-1804


91. Bradlow HL, Telang NT, Sepkovic DW, Osborne MP.

2-Hydroxyestrone: the ‘good’ estrogen.

Journal of Endocrinology 1996;150:S259-S265


92. Fishman JH, Gonzalez A, Osborne MP.

Breast cancer cells cultured in a system of new design presecrete an extracellular matrix and proliferate within it without cell-cell adhesion.

Biochemical and Biophysical Research Communication 1996;220:467-471


93. Bradlow L, Telang NT, Osborne MP.

Estrogen metabolites as bioreactive modulators of tumor initiators and promoters.

Advances in Experimental Medical Biology 1996;387:285-296


94. Katdare M, Singhal H, Newmark H, Osborne MP, Telang NT.

Prevention of mammary preneoplastic transformation by naturally-occurring tumor inhibitors.

Cancer Letter 1997;111:141-147


95. Telang NT, Katdare M, Bradlow HL, Osborne MP.

Estradiol metabolism: An endocrine biomarker for modulation of human mammary carcinogenesis.

Environmental Health Perspectives 1997;105 Suppl:559-564


96. Singhal H, Potter C, Osborne MP.

No effect of timing of biopsy in the menstrual cycle on incidence of bone marrow micrometastasis in patients with breast cancer.

Annals of Surgical Oncology 1997; 4:503-505


97. Telang NT, Katdare M, Bradlow HL, Osborne MP, Fishman J.

Inhibition of proliferation and modulation of estradiol metabolism: Novel mechanisms for breast cancer prevention by the phytochemical indole-3-carbinol.

Proceedings of the Society for Experimental Biology and Medicine 1997; 216:246-252


98. Simmons RM, Osborne MP.

Dilemmas in breast disease: Prophylactic mastectomy.

Breast Journal 1997;3:372-379


99. Zakowski SG, Valdimardottir HB, Bovbjerg DH, Borgen P, Holland J, Kash K, Miller DG, Mitnick J, Osborne MP, Van Zee K.

Predictors of intrusive thoughts and avoidance in women with family histories of breast cancer.

Annals of Behavioral Medicine 1997;19:362-369


100. Bergstein I, Eisenberg LM, Bhalerao J, Jenkins NA, Copeland NG, Osborne MP, Bowcock AM,

Brown AMC.

Isolation of two novel WNT genes, WNT 14 and WNT 15, one of which (WNT15) is closely linked to WNT3 on human chromosome 17q21.

Genomics 1997;46:450-458.


101. Robson M, Dabney MK, Rosenthal G, Ludwig S, Seltzer MH, Gilewski T, Haas B, Osborne MP, Norton L, Gilbert F, Offit K.

Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer.

Genetic Testing 1997;1:47-51


102. Wong GYC, Bradlow L, Sepkovic D, Mehl S, Mailman J, Osborne MP.

Dose-ranging study of indole-3-carbinol for breast cancer prevention.

Journal of Cellular Biochemistry 1997;Supplements 28/29:111-116


103. Telang NT, Inoue S, Bradlow HL, Osborne MP.

Negative growth regulation of oncogene-transformed mammary epithelial cells by tumor inhibitors.

Advances in Experimental Medicine and Biology 1997;400A:409-418


104. Gilbert F, Dabney MK, Diemer K, Ludwig S, Rosenthal G, Osborne MP.

BRCA1/BRCA2 mutations and breast cancer in Ashkenazi Jewish women.

Annals of the New York Academy of Sciences 1997;833:198-203.


105. Davis DL, Telang NT, Osborne MP, Bradlow HL.

Medical hypothesis: bifunctional genetic-hormonal pathways to breast cancer.

Environmental Health Perspectives 1997;105, Suppl3:571-576.


106. Telang NT, Arcuri F, Granata OM, Bradlow HL, Osborne MP, Castagnetta L.

Alteration of oestradiol metabolism in myc oncogene-transfected mouse mammary epithelial cells.

British Journal of Cancer 1998; 77:1549-1554


107. Bradlow HL, Sepkovic DW, Klug T, Osborne MP.

Application of an improved ELISA assay to the analysis of urinary estrogen metabolites.

Steroids 1998; 63:406-413


108. Giess CS, Keating DM, Osborne MP, Ng YY, Rosenblatt R.

Retroareolar breast carcinoma: clinical, imaging, and histopathologic features.

Radiology 1998; 207: 669-673


109. Breuer B, Smith S, Thor A, Edgerton S, Osborne MP, Minick R, Cody HS 3rd, Nowak E, Cortese A, Simmons RM, Carney WP, Brandt-Rauf PW.

ErbB-2 protein in sera and tumors of breast cancer patients.

Breast Cancer Research Treatment 1998;49:261-70


110. Oliveria S, Christos PJ, Visintainer PF, McDougall CJ, Osborne MP.

Patterns of colon cancer screening among companies in the U.S.: A descriptive survey.

American Journal of Health Promotion 1999;13:146-148.


111. Jinno H, Steiner MG, Mehta RG, Osborne MP, Telang NT.

Inhibition of aberrant proliferation and induction of apoptosis in HER-2/neu oncogene transformed human mammary epithelial cells by N-(4-hydroxyphenyl) retinamide.

Carcinogenesis 1999;20:229-236.


112. Yagmur Y, Prasad MJ, Osborne MP.

Myofibroblastoma in the irradiated breast.

Breast Journal 1999;5:136-140.


113. Taioli E, Bradlow HL, Garbers VV, Sepkovic DW, Osborne MP, Trachman J, Ganguly S, Garte SJ.

Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer risk.

Cancer Detection and Prevention 1999;23:232-237.


114. Giess CS, Keating DM, Osborne MP, Rosenblatt R.

Local tumor recurrence following breast-conservation therapy: Correlation of histopathologic findings with detection method and mammographic findings.

Radiology 1999;212:829-835.


115. Suto A, Telang NT, Tanino H, Takeshita T, Ohmiya H, Osborne MP, Kubota T.

In vitro and in vivo modulation of growth regulation in the human breast cancer cell line MCF-7 by estradiol metabolites.

Breast Cancer – Journal of the Japanese Breast Cancer Society 1999;6:87-92


116. Simmons RM, Fish SK, Gayle L, LaTrenta GS, Swistel A, Christos P, Osborne MP. Local and distant recurrence rates in skin-sparing mastectomies compared with non-skin-sparing mastectomies.

Annals of Surgical Oncology 1999;6:676-681


117. Simmons RM, Osborne MP.

The evaluation of high risk and pre-invasive breast lesions and the decision process for follow up and surgical intervention.

Surgical Oncology 1999;8:55-65


118. Prasad ML, Osborne MP, Giri DD, Hoda SA.

Microinvasive Carcinoma (T1mic) of the Breast: Clinicopathologic Profile of 21 Cases.

American Journal of Surgical Pathology 2000;24:422-428.


119. Shin SJ, Osborne MP, Moore A, Hayes MK, Hoda SA.

Determination of size in invasive breast carcinoma: Pathologic considerations and clinical implications.

American Journal of Clinical Pathology 2000;113:19-S29


120. Saqi A, Osborne MP, Rosenblatt R, Shin SJ, Hoda SA.

Quantifying mammary duct carcinoma in situ: A wild goose chase?

American Journal of Clinical Pathology 2000;113:30-S37


121. Rivadeneira DE, Simmons RM, Christos PJ, Hanna K, Daly JM, Osborne MP.

Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: Analysis in more than 900 patients.

Journal of the American College of Surgeons 2000;191:1-8


122. Rivadeneira DE, Simmons RM, Fish SK, Gayle L, La Trenta GS, Swistel A, Osborne MP.

Skin-sparing mastectomy with immediate breast reconstruction: A critical analysis of local recurrence.

Cancer Journal 2000;6:331-35


123. Telang NT, Katdare M, Bradlow HL, Osborne MP.

Cell cycle regulation, apoptosis and estradiol biotransformation: novel endpoint biomarkers for human breast cancer prevention.

Journal of Clinical Ligand Assay 2000;23:130-137


124. Giess CS, Keating DM, Osborne MP, Mester J, Rosenblatt R.

Comparison of rate of development and rate of change for benign and malignant breast calcifications at the lumpectomy bed.

American Journal of Roentgenology 2000;175:789-93.


125. Rosenbaum Smith SM, Osborne MP.

Breast cancer chemoprevention.

American Journal of Surgery 2000;180:249-251


126. Simmons R, Hoda S, Osborne MP.

Bone marrow Micrometastases in breast cancer patients.

American Journal of Surgery 2000;180:309-312


127. Shaikh N, LaTrenta G, Swistel A, Osborne MP.

Detection of recurrent breast cancer after tram flap reconstruction.

Annals of Plastic Surgery 2001; 47:602-607


128. Simmons RM, Brennan MB, Christos P, Sckolnick M, Osborne MP.

Recurrence rates in patients with central or retroareolar breast cancers treated with mastectomy or lumpectomy.

American Journal of Surgery 2001; 182:325-329


129. Simmons RM, Smith SM, Osborne MP.

Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization.

Breast Journal 2001; 7:181-183


130. Simmons R, Brennan M, Christos P, King V, Osborne MP.

Analysis of nipple/areolar involvement with mastectomy: Can the areola be preserved?

Annals of Surgical Oncology 2002; 9:165-168


131. Jinno H, Steiner MG, Nason-Burchenal K,Osborne MP, Telang NT.

Preventive efficacy of receptor class selective retinoids on HER-2/neu oncogene expressing preneoplastic human mammary epithelial cells.

International Journal of Oncology 2002; 21:127-134


132. Katdare M, Osborne MP, Telang NT

Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells.

International Journal of Oncology 2002; 21:809-815


133. Hoda SA, Chiu A, Resetkova E, Harigopal M, Hoda RS, Osborne MP

Pathological Examination of Sentinel Lymph Node in Breast Cancer: Potential Problems and Possible Solutions.

Microscopy Research and Technique 2002; 59:85-91


134. Katdare M, Osborne MP, Telang NT

Novel cell culture models for prevention of human breast cancer (Review)

International Journal of Oncology 2003: 22:509-515


135. Simmons R and Osborne MP

Diseases of the Breast

Rakel and Bope: Conn’s Current Therapy 2003; 1125-1130


136. Simmons R, Adamovich T, Brennan M, Christos P, Schultz M, Eisen C, Osborne MP

Nonsurgical Evaluation of Pathologic Nipple Discharge.

Annals of Surgical Oncology 2003; 10:113-116


137. Simmons R, Adamovich T, Brennan M, Christos P, Schultz M, Eisen C, Osborne MP

Nonsurgical evaluation of pathologic nipple discharge.

Annals of Surgical Oncology 2003; 10:113-116


138. Simmons R, Thevarajah S, Brennan MB, Christos P, Osborne MP

Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization.

Annals of Surgical Oncology 2003; 10:208-9


139. Hollenbeck ST, Cellini C, Christos P, Varnado-Rhodes Y, Martins D, Nussbaum M, Osborne MP, Simmons R.

Breast cancer in patients with residual invasive carcinoma is more accurately staged with additive tumor size Assessment.

Annals of Surgical Oncology 2003; 11:59-64


140. Sauven P, on behalf of the Association of Breast Surgery Family History Guidelines Panel (Osborne MP et al)

Guidelines for the management of women at increased familial risk of breast cancer

European Journal of Cancer 2004; 40:653-665


141. Osborne MP  Micrometastases in bone marrow. European Journal of Cancer 2004;2S:67-68


142. Gold HT, Do HT, Osborne MP

Cost-effectiveness of isosulphan blue vs. methylene blue in sentinel node biopsy.

Proceedings of the American Society of Clinical Oncology 2005; 23: # 16s 553s 6103


143. Crawford CV, Osborne MP, Katdare M

Identification of cell cycle and apoptosis related gene expression by curcumin in an in vitro model for duct carcinoma in situ.

Proceedings of the American Association of Cancer Research 2005;46:1011 Abstract #4279


144. Tsai A, Trichter S, Sabbas A, Swistel A, Osborne MP, Hoda S, Nori D, Hayes MK

Short-term outcome of mammosite brachytherapy: A single institution’s clinical experience.

American Society of Therapeutic Radiation Oncology  2006 (in press)




145. Schwarz GS, Drotman M, Rosenblatt R, Milner L, Shamonki J, Osborne MP

 Fibromatosis of the breast: case report and current concepts in the management of an uncommon lesion

 Breast Journal 2006; 12:66-71


146. Gronwald J, Tung N, Foulkes WD, Offit K, Gershoni R, Daly M, Kim-Sing C, Olsson H, Ainsworth P, Eisen A, Saal H, Friedman E, Olopade O, Osborne MP, Weitzel J, Lynch H, Ghadirian P, Lubinski J, Sun P, Narod SA. Hereditary Breast Cancer Clinical Study Group

 Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update

 International Journal of Cancer 2006; 118:2281-2284


147. Friedman E, Kotsopoulos J, Lubinski J, Lynch HT, Ghadirian P, Neuhausen SL, Isaacs C, Weber B, Foulkes WD, Moller P, Rosen B, Kim-Sing C, Gershoni-Baruch R, Ainsworth P, Daly M, Tung N, Eisen A, Olopade OI, Karlan B, Saal HM, Garber JE, Rennert G, Gilchrist D, Eng C, Offit K, Osborne M, Sun P, Narod SA. Hereditary Breast Cancer Clinical Group

Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers

Breast Cancer Research 2006;8: Epub 2006 Mar 21


148. Huston TL, Pigalarga R, Osborne MP, Tousimis E

The influence of additional surgical margins on the total specimen volume excised and the reoperative rate after breast-conserving surgery

American Journal of Surgery 2006; 192:509-12






149. Osborne MP

William Stewart Halsted: His life and contributions to cancer

Lancet Oncology 2007; 8:256-65


150. Cheung K, Tam W, Chuang E, Osborne MP

 Concurrent invasive ductal carcinoma and chronic lymphocytic leukemia  manifesting as a collision tumor in the breast

Breast Journal 2007;13:413-17


151. Kotspoulos J, Lubinski J, Lynch HT,Klijn J, Ghadirian P, Neuhausen SL, Kim-Sing C, Foulkes WD, Moller P, Isaacs C, Domcheck S, Randall S, Offit K, Tung N, Ainsworth P, Gershoni-Baruch R, Eisen A, Daly M, Karlan B, Saal HM, Couch F, Pasini B, Wagner T, Friedman E, Rennert G, Eng C, Weitzel J, Sun P, Narod SA;, Garber J, Osborne M, Fishman D, McLennan J, McKinnon W, Merajver S, Olsson H, Provencher D, Pasche B, Evans G, Meschino WS, Lemire E, Chudley A Rayson D, Bellati C Hereditary Breast Cancer Clinical Study Group

Age at first birth and the risk of breast cancer in BRCA 1 and BRCA 2 mutation carriers

Breast Cancer Research and Treatment 2007; 105:221-228


152. Tousimis E, Osborne MP

Diseases of the breast

In: Conn’s Current Therapy Eds: Rakel RE and Bope ET: 2007




153. Arora N, Martins D, Huston TL, Christos P, Hoda S, Osborne MP, Swistel AJ, Tousimis E, Pressman PI, Simmons RM.

Sentinel node positivity rates with and without frozen section for breast cancer.

Ann Surg Oncol. 2008;15:256-261


154. Arora N, Martins D, Ruggerio D, Tousimis E, Swistel AJ, Osborne MP, Simmons RM.

Effectiveness of a noninvasive digital infrared thermal imaging system in the detection of breast cancer.

American Journal of Surgery 2008:196:523-526.


155. Vaidya J, Osborne MP

An uncommon (hepatic) scintiscan during sentinel node biopsy--an optical illusion.

International Journal of Surgery 2008; 6:422-423.


156. Eisen A, Lubinski J, Gronwald J, Moller P, Lynch HT, Klijn J, Kim-Sing C, Neuhausen SL, Gilbert L, Ghadirian P, Manoukian S, Rennert G, Friedman E, Isaacs C, Rosen E, Rosen B, Daly M, Sun P, Narod SA. Hereditary Breast Cancer Clinical Study Group.

Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers

 Journal of the National Cancer Institute 2008;100:1361-7157.


157. Asad J, Jacobson AF, Estabrook A, Smith SR, Boolbol SK, Feldman SM, Osborne MP, Boachie-Adjei K, Twardzik W, Tartter PI.

Does Oncotype DX recurrence score affect the management of patients with early-stage breast cancer?

American Journal of Surgery 2008;196:527-158.


158. Metcalfe KA, Lubinski J, Ghadirian P, Lynch H, Kim-Sing C, Friedman E, Foulkes WD, Domchek S, Ainsworth P, Isaacs C, Tung N, Gronwald J, Cummings S, Wagner T, Manoukian S, Møller P, Weitzel J, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group

Predictors of contralateral prophylactic mastectomy in women with a BRCA 1 or BRCA 2 mutation                                                                                                                                                                                                                                                                                                                                Journal of Clinical Oncology 2008;26:1093-7


159. Jacobson AF, Asad J, Boolbol SK, Osborne MP, Boachie-Adjei K, Feldman SM.

Do additional shaved margins at the time of lumpectomy eliminate the need for re-excision?

American Journal of Surgery 2008;196:556-8


160. Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, Gronwald J, Lynch H, Moller P, Ghadirian P, Foulkes WD,

Klijn J, Friedman E, Kim-Sing C, Ainsworth P, Rosen B, Domchek S, Wagner T, Tung N, Manoukian S, Couch F, Sun P, Narod SA;

Hereditary Breast Cancer Clinical Study Group.

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.                                                                                                                                                            International Journal of Cancer 2008;122:2017-22




161. Ginsburg O, Ghadirian P, Lubinski J, Cybulski C, Lynch H, Neuhausen S, Kim-Sing C, Robson M, Domchek S, Isaacs C, Klijn J, Armel S, Foulkes WD, Tung N, Moller P, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group.

Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update.

Breast Cancer Research and Treatment 2009;114:127-35


162. Chadha M, Trombetta M, Boolbol S, Osborne MP.

Managing a small recurrence in the previously irradiated breast. Is there a second chance for breast conservation?

Oncology 2009;23:933-40


163. Osborne MP, Boolbol S

 Breast anatomy and development.

In: Diseases of the Breast, 4th Edition.  Eds:  J Harris, M Lippman, M Morrow, C Osborne

Lippincott, Philadelphia 2009



164. Osborne MP, Asad, J

Benign Breast Disease

In: Kuerer’s Breast Surgical Oncology Ed: H Kuerer

McGraw Hill, New York 2010


165. Ginsburg OM, Kim-Sing C, Foulkes WD, Ghadirian P, Lynch HT, Sun P, Narod SA: Hereditary Breast Cancer Clinical Study Group.

BRCA1and BRCA2 families and the risk of skin cancer.

Familial Cancer. 2010;9:489-93


166. Metcalfe K, Lubinski J, Lynch HT, Ghadirian P, Foulkes WD, Kim-Sing C, Neuhausen S,

Tung N, Rosen B, Gronwald J, Ainsworth P, Sweet K, Eisen A, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group.

Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations.

Journal of the National Cancer Institute 2010;102:1874-8


167. Dennis J, Ghadirian P, Little J, Lubinski J, Gronwald J, Kim-Sing C, Foulkes W, Moller P, Lynch HT, Neuhausen SL,

Domchek S, Armel S, Isaacs C, Tung N, Sweet K, Ainsworth P, Sun P, Krewski D, Narod S; Hereditary Breast Cancer Clinical Study Group.

Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriers.

Breast. 2010;19:479-83


168. Pal T, Keefe D, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group.

Fertility in women with BRCA mutations: a case-control study.

Fertil Steril. 2010;93:1805-8




169. Chuang E, Christos P, Flam A, McCarville K, Forst M, Shin S, Vahdat L, Swistel A, Simmons S, Osborne M, Moore A, Mazundar, M, Klein P.

Breast cancer subtypes in Asian-Americans differ according to Asian ethnic group

Journal of Immigrant and Minority Health 2012;5:754-8




170. Early-stage breast cancer treated with 3-week accelerated whole-breast radiation therapy and concomitant boost.

Chadha M, Woode R, Sillanpaa J, Lucido D, Boolbol SK, Kirstein L, Osborne MP,

Feldman S, Harrison LB.

International Journal of Radiation Oncology Biology and Physics 2013;86:40-4




171. Osborne MP, Boolbol S

Breast anatomy and development.

In: Diseases of the Breast, 5th Edition.  Eds: J Harris, M Lippman, M Morrow, C Osborne

Lippincott, Philadelphia 2014





172. The Lehmann model with time-dependent covariates.

Yu Q, Wong GYC, Osborne M.P, Hsu Y, Ai X.

Communications in Statistics - Theory and Methods. (In press)